Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hyperphagia 9 Malnutrition 4 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Hematologic Neoplasms 2 Postoperative Complications 1 Nutritional Support 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 Glucocorticoid Receptor Deficiency 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Disease Progression 1 Digestive System Neoplasms 1 Deglutition Disorders 1

Interventions

Irinotecan 10 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 Gemcitabine 8 Paclitaxel 7 Cisplatin 7 Capecitabine 7 Oxaliplatin 6 130-nm albumin-bound paclitaxel 6 Albumin-Bound Paclitaxel 5 napabucasin 4 Sorafenib 4 Drug Therapy 4 Cetuximab 4 pembrolizumab 3 apatinib 3 Radiotherapy 3 Ocoxin 3 Imatinib Mesylate 3 Folfox protocol 3 Everolimus 3 tislelizumab 2 spartalizumab 2 palbociclib 2 entinostat 2 encorafenib 2 camrelizumab 2 anlotinib 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive System Neoplasms × Parenteral Nutrition × Clear all

NCT03115957 2020-09-29

PNASIT

Jinling Hospital, China

Phase NA Completed

Gastrointestinal

Digestive System Neoplasms, Hyperphagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡